,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-10-04 08:25:00,"Today's Research Daily features new research reports on 17 major stocks, including Home Depot (HD), Union Pacific (UNP), Accenture (ACN) and Broadcom (AVGO).",0.03735268861055374,0.00768094789236784,0.9549663662910461,neutral,0.029671739786863327
1,2016-10-04 08:25:00,Home Depot shares have lagged the broader market this year on concerns about competitive pressures from specialty stores and mass retailers as well as the impact of the uneven economic recovery on discretionary spending.,0.025783251971006393,0.9581193327903748,0.016097359359264374,negative,-0.9323360919952393
2,2016-10-04 08:25:00,"But the Zacks analyst likes this buy-rated home-improvement retailer for its focus on improving customer experience, solid execution, leverage to the steadily housing market, a track record of capital discipline and returning excess to shareholders through dividends (currently yields an attractive 2.1%) and share buybacks.",0.8407604694366455,0.013372587040066719,0.14586687088012695,positive,0.8273878693580627
3,2016-10-04 08:25:00,"(You can read the full research report on Home Depot here >> )

Union Pacific shares have been star performers this year (the stock is up more than 24% year-to-date) despite well-known issues in the factory space given the railroad operator's track record of operating efficiencies and strong cash flows.",0.9514549374580383,0.024520717561244965,0.024024317041039467,positive,0.9269342422485352
4,2016-10-04 08:25:00,The Zacks analyst is impressed with buy-rated Union Pacific's strong cost discipline and a history of returning excess cash to shareholders through share buybacks and dividend payments.,0.8700976371765137,0.017603864893317223,0.11229843646287918,positive,0.8524937629699707
5,2016-10-04 08:25:00,"(You can read the full research report onUnion Pacifichere >> )

Accenture shares have led the broader business services space and the market (the stock is up almost 17% year-to-date), with the momentum expected to continue following the recent better-than-expected quarterly results.",0.9506509900093079,0.02001575194299221,0.029333245009183884,positive,0.9306352138519287
6,2016-10-04 08:25:00,"In the updated research report issued by the Zacks analyst today, he explains the positive attributes of this buy-rated stock, particularly the latest product additions in the analytics application space, given the increasing demand for digital solutions.",0.8809218406677246,0.01201186515390873,0.10706635564565659,positive,0.8689099550247192
7,2016-10-04 08:25:00,Accenture's investment in digital and marketing capabilities and its strategy of growing through acquisitions is another positive.,0.8760108351707458,0.011971432715654373,0.11201777309179306,positive,0.864039421081543
8,2016-10-04 08:25:00,"The analyst also points out this consulting firm's strong balance sheet, cash flows and a history of returning excess cash to shareholders.",0.6654269695281982,0.02604164369404316,0.30853143334388733,positive,0.6393853425979614
9,2016-10-04 08:25:00,"(You can read the full research report onAccenturehere>> )

Positive momentum in the Strong Buy rated Broadcom shares (the stock is up more than 18% year-to-date) are sustainable given continued synergistic benefits the Avago merger.",0.95148104429245,0.018609104678034782,0.0299097690731287,positive,0.93287193775177
10,2016-10-04 08:25:00,"The Zacks analyst also points out the company's efficient global supply chain with a variable, low-cost operating model that enables it to maintain sustainable revenue growth and expand margins.",0.9352612495422363,0.01430500764399767,0.05043382570147514,positive,0.9209562540054321
11,2016-10-04 08:25:00,"(You can read the full research report onBroadcomhere>> )

Other noteworthy reports we are featuring today include Toyota (TM), Netflix (NFLX) and AstraZeneca (AZN).",0.04084828123450279,0.005954195279628038,0.9531974792480469,neutral,0.03489408642053604
12,2016-10-04 08:25:00,"Would you like to see a hand-picked ""all-star"" selection of investment ideas from the man who heads up Zacks' trading and investing services?",0.09129321575164795,0.008137785829603672,0.900568962097168,neutral,0.08315543085336685
13,2016-10-04 08:25:00,Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand.,0.09629896283149719,0.00972762145102024,0.8939734697341919,neutral,0.0865713432431221
14,2016-10-04 08:25:00,"Click for his prized selections right now >>

You can find all of today's stock research reports here >>

Note: If you want an email notification each time Sheraz publishes a new article, pleaseclick here>>>

Union Pacific's (UNP) 3Q16 Likely to Be Aided by Lower Costs

The Zacks analyst believes that the phase II Eylea/rinucumab combination data is unimpressive and will not help Regeneron in its efforts to expand Eylea's label into additional indications.",0.08665262907743454,0.8520098924636841,0.06133757159113884,negative,-0.765357255935669
15,2016-10-04 08:25:00,"The covering analyst thinks Honda's focus on product and infrastructure development, and rapid expansion in Asia are tailwinds.",0.07356029748916626,0.8379793167114258,0.08846037089824677,negative,-0.7644190192222595
16,2016-10-04 08:25:00,Syngenta has expanded its production capacities in Brazil and Switzerland.,0.9484115242958069,0.014761410653591156,0.03682709112763405,positive,0.9336501359939575
17,2016-10-04 08:25:00,"The company intends to underpin business with new innovations, wider operations and ChemChina's deal.",0.9173019528388977,0.012826269492506981,0.069871686398983,positive,0.9044756889343262
18,2016-10-04 08:25:00,"Netflix (NFLX) Likely to be Acquired by Disney

The Zacks analyst opines that Netflix's strength in original programming makes it an attractive takeover target for media companies like Disney and others.",0.9102379083633423,0.014617321081459522,0.07514476031064987,positive,0.895620584487915
19,2016-10-04 08:25:00,"Fifth Third's growth prospects are encouraging given its diverse revenue sources, rising loans and deposits and strategic moves like branch consolidations.",0.928854763507843,0.014330718666315079,0.05681442841887474,positive,0.9145240187644958
20,2016-10-04 08:25:00,The Zacks analyst thinks TD Ameritrade should gain from its moves like product innovation & technology upgrade.,0.9249392747879028,0.01484136376529932,0.06021939590573311,positive,0.9100978970527649
21,2016-10-04 08:25:00,"The Zacks analyst believes Assurant is poised for growth given business restructuring, robust Solutions business and disciplined capital management.",0.9338403940200806,0.013625888153910637,0.05253373086452484,positive,0.9202145338058472
22,2016-10-04 08:25:00,The Zacks analyst is impressed with Newmont's efforts to reduce cost and debt.,0.9187177419662476,0.020013684406876564,0.06126847118139267,positive,0.8987040519714355
23,2016-10-04 08:25:00,The company is also making notable progress with its growth projects that should boost its production performance.,0.9510288238525391,0.015936991199851036,0.03303416445851326,positive,0.9350918531417847
24,2016-10-04 08:25:00,The covering analyst thinks Molson Coors will gain from the MillerCoors acquisition.,0.9445345997810364,0.018127743154764175,0.037337757647037506,positive,0.9264068603515625
25,2016-10-04 08:25:00,"The deal closure is dependent upon the Ab InBev- SABMiller merger, expected next week.",0.021154282614588737,0.6078020930290222,0.3710435926914215,negative,-0.5866478085517883
26,2016-10-04 08:25:00,"Toyota (TM) to Gain from Expansion in Emerging Markets

The Zacks analyst believes Toyota's focus on product development, capacity increases and expansion in emerging markets are positives.",0.9326945543289185,0.014187064953148365,0.053118400275707245,positive,0.9185075163841248
27,2016-10-04 08:25:00,The Zacks analyst believes that a highly competitive market for blood glucose monitoring devices and rising operational expenditure and product development costs are going to hurt Dexcom's margins.,0.021252837032079697,0.9653413891792297,0.013405696488916874,negative,-0.9440885782241821
28,2016-10-04 08:25:00,"The covering analyst thinks that though markets like North America, Japan and India remain strong, continued weakness in emerging markets like China, Russia and Brazil is holding back sales growth.",0.037797942757606506,0.949520468711853,0.012681491672992706,negative,-0.9117225408554077
29,2016-10-04 08:25:00,"AstraZeneca's core products, Nexium and Crestor, continue to be under pressure due to generic competition.",0.02324065752327442,0.929326057434082,0.047433290630578995,negative,-0.9060853719711304
30,2016-10-04 08:25:00,The Zacks analyst thinks the outlook for 2016 is also disappointing.,0.018379995599389076,0.9567629098892212,0.024857167154550552,negative,-0.9383829236030579
31,2016-10-04 08:25:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
32,2016-10-04 08:25:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
33,2016-10-04 08:25:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
34,2016-10-04 08:25:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
